2024

Csergeová L, Krbušek D, Janoštiak R. CIP/KIP and INK4 families as hostages of oncogenic signaling. Cell Div. 2024 Apr 1;19(1):11. doi: 10.1186/s13008-024-00115-z. (IF 2.3 / Q4) [Pubmed]

Škarková A, Bizzarri M, Janoštiak R, Mašek J, Rosel D, Brábek J. Educate, not kill: treating cancer without triggering its defenses. Trends Mol Med. 2024 Apr 23:S1471-4914(24)00091-1. doi: 10.1016/j.molmed.2024.04.003. Epub ahead of print. (IF 13.6 / Q1) [PubMed]

2023

Dave J, Jagana V, Janostiak R, Bisserier M. Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development. J Transl Med. 2023 Jul 17;21(1):477. doi: 10.1186/s12967-023-04339-5. (IF 7.4 / Q1) [PubMed]

Lerner G, Tang H, Singh K, Golestani R, St Claire S, Humphrey PA, Lannin D, Janostiak R, Harigopal M. AMACR Expression is a Potential Diagnostic Marker in Apocrine Lesions of Breast, and is Associated with High Histologic Grade and Lymph Node Metastases in Some Invasive Apocrine Breast Cancers. Clin Breast Cancer. 2023 Feb;23(2):199-210. doi: 10.1016/j.clbc.2022.11.012. (IF 3.1 / Q3) [PubMed]

Herceg S, Janoštiak R. Diagnostic and Prognostic Profiling of Nucleocytoplasmic Shuttling Genes in Hepatocellular Carcinoma. Folia Biol (Praha). 2023;69(4):133-148. doi: 10.14712/fb2023069040133. (IF 0,6 / Q4) [PubMed]